Hyundai Pharm has newly appeared among the top searched stocks.

As of 2:31 PM on the 12th, Hyundai Pharm is trading at 7,110 KRW, down 1.39% from the previous day. This represents a 48.74% increase compared to May 19. Hyundai Pharm is known as a manufacturer of health beverages such as Miero Fiber and pharmaceuticals.

Today, foreigners have net purchased 4,000 shares of Hyundai Pharm, while institutions have net sold 7,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 183,387 shares, while foreigners and institutions have net sold 95,121 shares and net purchased 103,078 shares, respectively.

On June 11, Hyundai Pharm became a market issue with the headline "Diabetes treatment license and clinical approval highlighted, causing a surge (comprehensive...)."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing